CMS Sanctions for Medicare Advantage & Prescription Drug Plans
Marketing and enrollment activities for Cigna HealthSpring’s Medicare Advantage and standalone prescription drug plans have been suspended until further notice due to CMS sanctions. As a result, you must cease marketing to and contacting potential enrollees on behalf of Cigna-HealthSpring. The suspension does not impact current Cigna-HealthSpring Medicare Advantage and Medicare Part D enrollees’ benefits or plans.
Cigna HealthSpring appreciates your prompt attention to this matter. They remain committed to your ongoing partnership and will keep you informed of developments as they work with CMS to return to active enrollment.